MedTrace Logo

Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China

NCT03577509 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-10-09

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the pharmacokinetics of single intravenous of Amphotericin B Colloidal Dispersion(ABCD)in Chinese healthy subjects.

Conditions

  • Invasive Fungal Disease

Interventions

DRUG

ABCD

Intravenous infusion of dexamethasone 5mg before ABCD intravenous administration; Single infusion.

Sponsors & Collaborators

  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jing Zhang, Ph.D · Huashan Hospital

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2018-09-14
Completion
2018-09-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577509 on ClinicalTrials.gov